HEPARINE SODIUM STEROP süstelahus Eesti - eesti - Ravimiamet

heparine sodium sterop süstelahus

sterop overseas s.a. laboratories - naatriumhepariin - süstelahus - 5000rÜ 1ml 5ml 10tk

HEPARIN SODIUM PANPHARMA süstelahus Eesti - eesti - Ravimiamet

heparin sodium panpharma süstelahus

panpharma laboratories - naatriumhepariin - süstelahus - 5000rÜ 1ml 5ml 10tk

HEPARIN SODIUM ROVI süstelahus Eesti - eesti - Ravimiamet

heparin sodium rovi süstelahus

laboratorios farmaceuticos rovi s.a. - naatriumhepariin - süstelahus - 5000tÜ 1ml 5ml 100tk

METAFLU süstelahus Eesti - eesti - Ravimiamet

metaflu süstelahus

synektik s.a. - naatriumfluoriid (18f) - süstelahus - 2gbq 1ml 15ml 1tk; 2gbq 1ml 25ml 1tk

DURAPHAT hambapasta Eesti - eesti - Ravimiamet

duraphat hambapasta

colgate-palmolive dental health unit. - naatriumfluoriid - hambapasta - 5000ppm 51g 1tk

DURAPHAT hambapasta Eesti - eesti - Ravimiamet

duraphat hambapasta

colgate-palmolive manufacturing (poland) sp. z o.o. - naatriumfluoriid - hambapasta - 5000ppm 51g 1tk

Pemetrexed Pfizer (previously Pemetrexed Hospira) Euroopa Liit - eesti - EMA (European Medicines Agency)

pemetrexed pfizer (previously pemetrexed hospira)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Pemetrexed Baxter Euroopa Liit - eesti - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Adrovance Euroopa Liit - eesti - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoos, postmenopausis - narkootikumid luuhaiguste raviks - menopausijärgse osteoporoosi ravi d-vitamiini puudulikkusega patsientidel. adrovance vähendab lülisamba ja puusaluu murrud.

Convenia Euroopa Liit - eesti - EMA (European Medicines Agency)

convenia

zoetis belgium sa - cefovecin (as sodium salt) - antibakteriaalsed ained süsteemseks kasutamiseks - dogs; cats - dogsfor ravi naha ja pehmete kudede infektsioonid, sh pyoderma, haavad ja abstsess seotud staphylococcus pseudintermedius, β-hemolüütiline streptokokkide, escherichia coli ja / või pasteurella multocida. escherichia coli ja / või proteus spp. seotud kuseteede infektsioonide raviks. mehhaanilise või kirurgilise perioodilise ravina täiendav ravi porphyromonas spp. seotud gingiva ja perioodiliste kudede tõsiste infektsioonide raviks. ja prevotella spp. catsfor ravi naha ja pehmete kudede abstsess ja haavad seotud pasteurella multocida, usobacterium spp. , bacteroides spp. , prevotella oralis, β-hemolüütilised streptokokid ja / või staphylococcus pseudintermedius. escherichia coliga seotud kuseteede infektsioonide raviks.